Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Expanded Invitrogen TrueEdit Tool Kit

Thermo Fisher Scientific has expanded its Invitrogen TrueEdit tool kit. The portfolio now includes the Invitrogen TrueCut Cas9 Protein v2, a recombinant Streptococcus pyogenes Cas9 protein for genome editing with CRISPR technology. This CRISPR-Cas9 protein is designed to deliver consistently high editing efficiency in all cell lines including standard, immune, primary, and stem. In addition, the firm's new product line of ready-to-transfect Invitrogen TrueGuide Synthetic gRNAs offers researchers a range of selections, from economical options for routine editing tasks to high-performance choices for editing in challenging cell types such as primary cells, immune cells, and stem cells. Thermo Fisher also offers predesigned synthetic gRNAs for the entire human and mouse genome, selected for maximum knockout efficiency and specificity.
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.